Recently, the World Health Organization releases a statement on the heated tobacco products and reminds its member states to fulfill their tobacco obligations based on the WHO Framework Convention of Tobacco Control (FCTC), particularly in relation to heat-not-burn products (HNB).
According to the statement:
“Heated tobacco products are tobacco products, meaning that the WHO FCTC fully applies to these products. [Rules] obliges Parties, to prohibit ‘all forms of tobacco advertising, promotion, and sponsorship that promote a tobacco product by any means that are false, misleading or deceptive or likely to create an erroneous impression about its characteristics, health effects, hazards or emissions.”
The Who claims that even though HNB products reducing exposure to harmful chemicals, it doesn’t mean these products are harmless, nor does it reduces risk to human health.
The organization further claimed in its release states that the health implications of HNB product exposure are still not clear. The statement noted:
“Indeed, some toxins are present at higher levels in [HNB] aerosols than in conventional cigarette smoke, and there are some additional toxins present in [HNB] aerosols that are not present in conventional cigarette smoke.”
Although the US Food and Drug Administration (FDA) had authorized the sales of an HNB product, Philip Morris’ IQOS, this can not be considered as proof that HNB products are safer than traditional cigarettes, as the WHO argued.
The WHO demonstrated:
“Given that health may be affected by exposure to additional toxins when using [HNB], claims that [HNB] products reduce exposure to harmful chemicals relative to conventional cigarettes may be misleading.
“Moreover, the relevant orders grant a temporary market authorization within the US and are based on factors specific to the US, which is not a Party to the WHO Framework Convention on Tobacco Control (WHO FCTC).”
This article is issued by vaporvoice, for more information, please check: